Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS

Summary

Several investigations have suggested that polyunsaturated fatty acids may promote therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent disability progression in patients with relapsing MS.This study will seek to measure disease activity as seen on MRI scans in addition to measuring relapse rates.

Timeline

Start

2008-03

Primary completion

2012-09

Completion

2012-09

Outcome

Outcome not reported

Stopped (Enrollment): “funding stopped due to slow enrollment.”

Drugs

Indications